Albumin-FMS-like tyrosine kinase 3 ligand (Johns Hopkins University)

N/A

Report date: 2025/03/17 09:43:49

Base Information

Drug NameAlbumin-FMS-like tyrosine kinase 3 ligand (Johns Hopkins University)
Drug Alias NameAlb-Flt3L
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFms-related tyrosine kinase 3 ligand modulators
TargetsFms-related tyrosine kinase 3 ligand
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A